Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Abeona Therapeutics Inc. Common Stock (ABEO)

Pharmaceutical Preparations

https://www.abeonatherapeutics.com

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.

6555 CARNEGIE AVE, 4TH FLOOR
CLEVELAND, OH

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/19/1980

Market Cap

213,756,564

Shares Outstanding

24,770,000

Weighted SO

24,773,317

Total Employees

N/A

Upcoming Earnings

08/13/2024

Similar Tickers

RVPH --.--%

ATHA --.--%

FBIO --.--%

ACAD --.--%

CABA --.--%

EVFMD --.--%

CALA --.--%

AFMD --.--%

CKPT --.--%

Beta

1.5800

Last Div

0.0000

Range

3.05-9.01

Chg

-0.0650

Avg Vol

423443

Mkt Cap

213756564

Exch

NASDAQ

Country

US

Phone

646 813 4701

DCF Diff

5.6860

DCF

-0.7060

Div Yield

0.0000

P/S

75.6928

EV Multiple

-3.7065

P/FV

2.6959

Div Yield %

0.0000

P/E

-3.7539

PEG

-0.1000

Payout

0.0000

Current Ratio

7.4752

Quick Ratio

7.4752

Cash Ratio

2.0640

DSO

211.9688

DIO

0.0000

Op Cycle

211.9688

DPO

292.8126

CCC

-80.8437

Gross Margin

-0.3679

Op Margin

-20.0910

Pretax Margin

-18.6257

Net Margin

-18.6257

Eff Tax Rate

-0.0092

ROA

-0.3925

ROE

-2.0785

ROCE

-0.4843

NI/EBT

1.0000

EBT/EBIT

0.9271

EBIT/Rev

-20.0910

Debt Ratio

0.1503

D/E

0.2751

LT Debt/Cap

0.1805

Total Debt/Cap

0.2157

Int Coverage

-603.5851

CF/Debt

-2.0948

Equity Multi

1.8296

Rec Turnover

1.7220

Pay Turnover

1.2465

Inv Turnover

0.0000

FA Turnover

0.3530

Asset Turnover

0.0211

OCF/Share

-1.0548

FCF/Share

-1.0927

Cash/Share

3.0753

OCF/Sales

-14.9444

FCF/OCF

1.0359

CF Coverage

-2.0948

ST Coverage

-10.5140

CapEx Coverage

-27.8200

Div&CapEx Cov

-27.8200

P/BV

2.6959

P/B

2.6959

P/S

75.6928

P/E

-3.7539

P/FCF

-4.8892

P/OCF

-4.6786

P/CF

-4.6786

PEG

-0.1000

P/S

75.6928

EV Multiple

-3.7065

P/FV

2.6959

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 15, 07:30 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. Nov 27, 07:30 Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA) GlobeNewswire Inc. Nov 13, 07:30 Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments GlobeNewswire Inc. Nov 01, 07:30 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.59 03/31/2000 11/30/-0001 11/30/-0001 11/30/-0001